Valuation: QHSLab, Inc.

Market Cap 45.1L 40.39L 37.15L 33.66L 62.92L 43Cr 64.1L 4.43Cr 1.78Cr 23Cr 1.69Cr 1.66Cr 71Cr P/E 2024
-8.27x
P/E 2025 30.3x
Enterprise Value 41.67L 37.32L 34.32L 31.1L 58.14L 40Cr 59.22L 4.09Cr 1.64Cr 21Cr 1.56Cr 1.53Cr 66Cr EV / Sales 2024
1.97x
EV / Sales 2025 2.41x
Free-Float
51.27%
Yield 2024 *
-
Yield 2025 -
1 day-3.23%
1 week-0.99%
Current month-6.25%
1 month-6.25%
3 months+15.38%
6 months-43.66%
Current year-50.49%
1 week 0.3
Extreme 0.3
0.34
1 month 0.3
Extreme 0.3
0.47
Current year 0.23
Extreme 0.233
1.14
1 year 0.18
Extreme 0.18
1.14
3 years 0.02
Extreme 0.0155
1.14
5 years 0.02
Extreme 0.0155
1.14
10 years 0
Extreme 0.005
1.14
Manager TitleAgeSince
Chief Executive Officer 49 28/06/2016
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 02/05/2024
Director TitleAgeSince
Chairman 49 28/06/2016
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/26 Héritage -22,26,280 14.8095%
31/12/25 Others

Chief Executive Officer

26,44,424 100.0000%
31/12/25 Conversion

Chief Executive Officer

2,13,075 1.8887%
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%-0.99%+65.29%+823.08% 45.1L
-1.72%+3.44%+25.31%+60.56% 26TCr
-2.00%+0.75%+7.99%+25.46% 16TCr
-3.73%-4.48%-18.49%+67.13% 15TCr
-1.66%-8.12%-58.26%-16.12% 6.08TCr
-2.57%+3.30%+10.22%+47.55% 5.3TCr
0.00%+2.46%-11.97%-6.29% 5.33TCr
-3.47%+1.04%+21.98%+72.85% 4.93TCr
+0.84%-3.12%+9.80%+64.47% 5.07TCr
-3.61%+1.99%+34.94%+95.49% 4.55TCr
Average -2.12%-0.37%+8.68%+123.42% 8.83TCr
Weighted average by Cap. -2.10%+0.15%+5.19%+47.80%

Financials

2024 2025
Net sales 21.32L 19.09L 17.56L 15.91L 29.75L 20Cr 30.3L 2.09Cr 84.08L 11Cr 80.01L 78.31L 34Cr 26.92L 24.11L 22.17L 20.09L 37.56L 26Cr 38.26L 2.64Cr 1.06Cr 13Cr 1.01Cr 98.87L 42Cr
Net income -3L -2L -2L -2L -4L -2.46Cr -4L -25.47L -10.22L -1.29Cr -10L -10L -4.08Cr 5L 4L 4L 3L 6L 4.34Cr 7L 44.94L 18.04L 2.28Cr 17.17L 16.8L 7.2Cr
Net Debt 15.79L 14.14L 13.01L 11.78L 22.03L 15Cr 22.44L 1.55Cr 62.26L 7.89Cr 59.25L 57.99L 25Cr -3L -3L -3L -3L -5L -3.26Cr -5L -33.72L -13.54L -1.71Cr -12.88L -12.61L -5.41Cr
Projected Income Statement - Annual - QHSLab, Inc.
Logo QHSLab, Inc.
QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Employees
12
Date Price Change Volume
30/26/30 $0.3000 -3.23% 3,008
29/26/29 $0.3100 +3.33% 1,899
28/26/28 $0.3000 -6.51% 1,018
27/26/27 $0.3209 +6.96% 1,001
26/26/26 $0.3000 -0.99% 5,763
  1. Stock Market
  2. Stocks
  3. USAQ Stock